{"id":"https://openalex.org/W2901281652","doi":"https://doi.org/10.1002/pds.4683","title":"Increases in controlled\u2010release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population\u2010based study","display_name":"Increases in controlled\u2010release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population\u2010based study","publication_year":2018,"publication_date":"2018-11-13","ids":{"openalex":"https://openalex.org/W2901281652","doi":"https://doi.org/10.1002/pds.4683","mag":"2901281652","pmid":"https://pubmed.ncbi.nlm.nih.gov/30421838","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6687879"},"language":"en","primary_location":{"id":"doi:10.1002/pds.4683","doi":"https://doi.org/10.1002/pds.4683","is_oa":true,"landing_page_url":"https://doi.org/10.1002/pds.4683","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.4683","source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.4683","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016316637","display_name":"Andrea L. Schaffer","orcid":"https://orcid.org/0000-0002-3701-4997","observed_orcids":["https://orcid.org/0000-0002-3701-4997"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405259469","display_name":"Centre for Big Data Research in Health","ror":"https://ror.org/029g70m06","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405259469"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Andrea L. Schaffer","raw_affiliation_strings":["Medicines Policy Research Unit, Centre for Big Data Research in Health University of New South Wales Sydney Australia"],"raw_orcid":"https://orcid.org/0000-0002-3701-4997","affiliations":[{"raw_affiliation_string":"Medicines Policy Research Unit, Centre for Big Data Research in Health University of New South Wales Sydney Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405259469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039494044","display_name":"Emily Aspasia Karanges","orcid":"https://orcid.org/0000-0001-7922-2762","observed_orcids":["https://orcid.org/0000-0001-7922-2762"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405259469","display_name":"Centre for Big Data Research in Health","ror":"https://ror.org/029g70m06","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405259469"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Emily A. Karanges","raw_affiliation_strings":["Medicines Policy Research Unit, Centre for Big Data Research in Health University of New South Wales Sydney Australia"],"raw_orcid":"https://orcid.org/0000-0001-7922-2762","affiliations":[{"raw_affiliation_string":"Medicines Policy Research Unit, Centre for Big Data Research in Health University of New South Wales Sydney Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405259469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040371388","display_name":"Nicholas Allan Buckley","orcid":"https://orcid.org/0000-0002-6326-4711","observed_orcids":["https://orcid.org/0000-0002-6326-4711"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Nicholas A. Buckley","raw_affiliation_strings":["School of Medical Sciences University of Sydney Sydney Australia"],"raw_orcid":"https://orcid.org/0000-0002-6326-4711","affiliations":[{"raw_affiliation_string":"School of Medical Sciences University of Sydney Sydney Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091821078","display_name":"Andrew J. Wilson","orcid":"https://orcid.org/0000-0002-1809-7846","observed_orcids":["https://orcid.org/0000-0002-1809-7846","https://orcid.org/0000-0002-9704-2332","https://orcid.org/0000-0001-9198-1243","https://orcid.org/0000-0003-3246-2958"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Wilson","raw_affiliation_strings":["Menzies Centre for Health Policy University of Sydney Sydney Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Menzies Centre for Health Policy University of Sydney Sydney Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007290128","display_name":"Louisa J Degenhardt","orcid":"https://orcid.org/0000-0002-8513-2218","observed_orcids":["https://orcid.org/0000-0002-8513-2218"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405258728","display_name":"National Drug and Alcohol Research Centre","ror":"https://ror.org/0144fat78","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Louisa Degenhardt","raw_affiliation_strings":["National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060125444","display_name":"Briony Larance","orcid":"https://orcid.org/0000-0003-3800-7673","observed_orcids":["https://orcid.org/0000-0003-3800-7673"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405258728","display_name":"National Drug and Alcohol Research Centre","ror":"https://ror.org/0144fat78","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Briony Larance","raw_affiliation_strings":["National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019760776","display_name":"Sallie\u2010Anne Pearson","orcid":"https://orcid.org/0000-0001-7137-6855","observed_orcids":["https://orcid.org/0000-0001-7137-6855"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405259469","display_name":"Centre for Big Data Research in Health","ror":"https://ror.org/029g70m06","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405259469"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Sallie\u2010Anne Pearson","raw_affiliation_strings":["Medicines Policy Research Unit, Centre for Big Data Research in Health University of New South Wales Sydney Australia","Menzies Centre for Health Policy University of Sydney Sydney Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Policy Research Unit, Centre for Big Data Research in Health University of New South Wales Sydney Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405259469"]},{"raw_affiliation_string":"Menzies Centre for Health Policy University of Sydney Sydney Australia","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5016316637"],"corresponding_institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405259469"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.4589,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.83012802,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"28","issue":"1","first_page":"97","last_page":"105"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/controlled-release-oxycodone","display_name":"controlled-release oxycodone","score":0.9290000200271606},{"id":"https://openalex.org/keywords/drug-subsidies","display_name":"drug subsidies","score":0.7329999804496765},{"id":"https://openalex.org/keywords/opioid-prescribing-patterns","display_name":"opioid prescribing patterns","score":0.6539999842643738},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.3930000066757202},{"id":"https://openalex.org/keywords/treatment-episodes","display_name":"treatment episodes","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C2776029756","wikidata":"https://www.wikidata.org/wiki/Q407535","display_name":"Oxycodone","level":4,"score":0.9912687540054321},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.7890762686729431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7878125905990601},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6651569604873657},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5116024613380432},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46988585591316223},{"id":"https://openalex.org/C3019981671","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Immediate release","level":2,"score":0.45927363634109497},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38904228806495667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23663681745529175},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010098","descriptor_name":"Oxycodone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010098","descriptor_name":"Oxycodone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D059350","descriptor_name":"Chronic Pain","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D059350","descriptor_name":"Chronic Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D065186","descriptor_name":"Interrupted Time Series Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/pds.4683","doi":"https://doi.org/10.1002/pds.4683","is_oa":true,"landing_page_url":"https://doi.org/10.1002/pds.4683","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.4683","source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:30421838","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30421838","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6687879","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6687879","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Pharmacoepidemiol Drug Saf","raw_type":"Text"},{"id":"pmh:oai:unsworks.library.unsw.edu.au:1959.4/unsworks_75254","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1959.4/unsworks_75254","pdf_url":"https://unsworks.unsw.edu.au/bitstreams/c1bdda6f-246a-4b0d-ad16-a9a136280e9a/download","source":{"id":"https://openalex.org/S4306401737","display_name":"UNSWorks (University of New South Wales, Sydney, Australia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40053085","host_organization_name":"Australian Defence Force Academy","host_organization_lineage":["https://openalex.org/I40053085"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacoepidemiology and Drug Safety, 28, 1, 97-105","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/284766","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11343/284766","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"10th Asian Conference on Pharmacoepidemiology","raw_type":"Conference Paper"}],"best_oa_location":{"id":"doi:10.1002/pds.4683","doi":"https://doi.org/10.1002/pds.4683","is_oa":true,"landing_page_url":"https://doi.org/10.1002/pds.4683","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.4683","source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G3292696704","display_name":null,"funder_award_id":"1073858","funder_id":"https://openalex.org/F4320322220","funder_display_name":"Department of Health and Aged Care, Australian Government"},{"id":"https://openalex.org/G445506642","display_name":null,"funder_award_id":"1135991","funder_id":"https://openalex.org/F4320322220","funder_display_name":"Department of Health and Aged Care, Australian Government"},{"id":"https://openalex.org/G4924787576","display_name":"Examination of the trajectories and health consequences of pharmaceutical opioid use in Australia","funder_award_id":"1073858","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G540683330","display_name":null,"funder_award_id":"#1041472","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G5884560987","display_name":null,"funder_award_id":"1041472","funder_id":"https://openalex.org/F4320322220","funder_display_name":"Department of Health and Aged Care, Australian Government"},{"id":"https://openalex.org/G6812693871","display_name":"Centre of Research Excellence in Medicines and Ageing","funder_award_id":"1060407","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G8367930492","display_name":"Using existing data to understand and ameliorate risk in opioid agonist therapy","funder_award_id":"R01DA044170","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8567362624","display_name":"Increasing knowledge about substance use, mental health and harms, and interventions to prevent and reduce harm","funder_award_id":"1135991","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320315885","display_name":"Australian Government","ror":"https://ror.org/0314h5y94"},{"id":"https://openalex.org/F4320322220","display_name":"Department of Health and Aged Care, Australian Government","ror":"https://ror.org/02swcnz29"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"},{"id":"https://openalex.org/F4320335233","display_name":"National Drug and Alcohol Research Centre","ror":"https://ror.org/03r8z3t63"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2901281652.pdf","grobid_xml":"https://content.openalex.org/works/W2901281652.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1497105793","https://openalex.org/W1898025493","https://openalex.org/W2040109649","https://openalex.org/W2069516629","https://openalex.org/W2073523765","https://openalex.org/W2082275407","https://openalex.org/W2082276527","https://openalex.org/W2128848460","https://openalex.org/W2139866653","https://openalex.org/W2175532134","https://openalex.org/W2296986887","https://openalex.org/W2300421333","https://openalex.org/W2397005921","https://openalex.org/W2466535264","https://openalex.org/W2772075684","https://openalex.org/W2781457855","https://openalex.org/W2783726333","https://openalex.org/W2791140527","https://openalex.org/W2793688987"],"related_works":["https://openalex.org/W3086319830","https://openalex.org/W2300421333","https://openalex.org/W2791140527","https://openalex.org/W1997116644","https://openalex.org/W2791926731","https://openalex.org/W7067200047","https://openalex.org/W2164484082","https://openalex.org/W1998276346","https://openalex.org/W4224708301","https://openalex.org/W2070066044"],"abstract_inverted_index":{"PURPOSE:":[0],"Despite":[1],"increasing":[2],"use":[3],"of":[4,49,51,78,102,115,123,133,137,152,225,245],"oxycodone/naloxone":[5,103,128,157,227],"controlled-release":[6],"(CR)":[7],"in":[8,26,45,75,87,111,149,167,188,242],"Australia,":[9],"little":[10],"is":[11],"known":[12],"about":[13],"how":[14],"it":[15,234],"has":[16],"affected":[17],"the":[18,46,112,135,223,237,246],"overall":[19],"oxycodone":[20,53,60,64,83,116,139,239,247],"CR":[21,54,57,65,84,104,117,140,228,248],"market":[22],"since":[23],"its":[24,221],"subsidy":[25,101],"2011.":[27],"METHODS:":[28],"We":[29,68],"used":[30],"Pharmaceutical":[31],"Benefits":[32],"Scheme":[33],"dispensing":[34,50,195,210],"claims":[35],"(2006-2016)":[36],"and":[37,58,62,90,147,205],"interrupted":[38],"time":[39],"series":[40],"analysis":[41],"to":[42,92,178,199],"examine":[43],"changes":[44],"quarterly":[47],"rates":[48],"oral":[52],"formulations":[55],"(oxycodone/naloxone":[56],"single-ingredient":[59,238],"CR)":[61],"new":[63,82,138,153],"treatment":[66,85,141,154],"episodes.":[67],"also":[69],"performed":[70],"a":[71,76,81,108,171],"retrospective":[72],"cohort":[73,132],"study":[74],"sample":[77],"people":[79,168,189],"initiating":[80,169,190],"episode":[86],"2009,":[88,162],"2012/2013,":[89],"2016":[91,160],"compare":[93],"opioid":[94,194,209],"utilisation":[95],"patterns":[96],"over":[97],"time.":[98],"RESULTS:":[99],"The":[100],"was":[105,229],"associated":[106],"with":[107,161,170,191,206],"1.6-fold":[109],"increase":[110,166],"growth":[113],"rate":[114],"dispensing,":[118],"resulting":[119,241],"from":[120],"rapid":[121],"uptake":[122,224],"low":[124],"strength":[125,173],"(\u22645":[126],"mg)":[127],"CR.":[129,158],"In":[130],"our":[131],"initiators,":[134],"number":[136],"episodes":[142,155],"increased":[143],"2.1-fold":[144],"between":[145],"2009":[146],"2016;":[148],"2016,":[150],"91.4%":[151],"involved":[156],"Comparing":[159],"we":[163],"observed":[164],"an":[165,243],"tablet":[172],"less":[174],"than":[175,231],"or":[176],"equal":[177],"5-mg":[179],"(risk":[180],"difference":[181],"[RD]":[182],"=":[183,202,216],"21.1%,":[184],"95%":[185],"CI,":[186],"19.9%-22.4%)":[187],"no":[192,207],"other":[193],"90":[196,211],"days":[197,212],"prior":[198],"initiation":[200,214],"(RD":[201,215],"5.2%,":[203],"3.8%-6.6%)":[204],"further":[208],"after":[213],"8.8%,":[217],"7.4%-10.2%).":[218],"CONCLUSIONS:":[219],"After":[220],"subsidy,":[222],"low-dose":[226],"greater":[230],"expected":[232],"if":[233],"were":[235],"substituting":[236],"CR,":[240],"expansion":[244],"market.":[249]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2018-11-29T00:00:00"}